Prevention is key in managing hyperacute rejection. Strategies include comprehensive pre-transplant screening for donor-specific antibodies, ensuring ABO and HLA compatibility, and possibly using desensitization protocols to reduce the levels of harmful antibodies in the recipient before transplantation.
